Citations

Showing 10 of 108104 citations.

Association of stay-at-home orders and COVID-19 incidence and mortality in rural and urban United States: a population-based study
Jiang, David H. , Roy, Darius J., Pollock, Benjamin D. , Shah, Nilay D. , McCoy, Rozalina G. , McCoy, Rozalina Grubina , Pollock, Benjamin D

Mayo Clinic

BMJ Open | April 7, 2022 | Volume: 12 | Issue: 4 | Pages: e055791

10.1136/bmjopen-2021-055791 | PMID 35393311 Get It

Objective We examined the association between stay-at-home order implementation and the incidence of COVID-19 infections and deaths in rural versus urban counties of the United States. Design We used an interrupted time-series analysis using a mixed effects zero-inflated Poisson model with random intercept by county and standardised by population to examine the associations between stay-at-home orders and county-level counts of daily new COVID-19 cases and deaths in rural versus urban counties between 22 January 2020 and 10 June 2020. We secondarily examined the association between stay-at-home orders and mobility in rural versus urban counties using Google Community Mobility Reports. Interventions Issuance of stay-at-home orders. Primary and secondary outcome measures Co-primary outcomes were COVID-19 daily incidence of cases (14-day lagged) and mortality (26-day lagged). Secondary outcome was mobility. Results Stay-at-home orders were implemented later (median 30 March 2020 vs 28 March 2020) and were shorter in duration (median 35 vs 54 days) in rural compared with urban counties. Indoor mobility was, on average, 2.6%–6.9% higher in rural than urban counties both during and after stay-at-home orders. Compared with the baseline (pre-stay-at-home) period, the number of new COVID-19 cases increased under stay-at-home by incidence risk ratio (IRR) 1.60 (95% CI, 1.57 to 1.64) in rural and 1.36 (95% CI, 1.30 to 1.42) in urban counties, while the number of new COVID-19 deaths increased by IRR 14.21 (95% CI, 11.02 to 18.34) in rural and IRR 2.93 in urban counties (95% CI, 1.82 to 4.73). For each day under stay-at-home orders, the number of new cases changed by a factor of 0.982 (95% CI, 0.981 to 0.982) in rural and 0.952 (95% CI, 0.951 to 0.953) in urban counties compared with prior to stay-at-home, while number of new deaths changed by a factor of 0.977 (95% CI, 0.976 to 0.977) in rural counties and 0.935 (95% CI, 0.933 to 0.936) in urban counties. Each day after stay-at-home orders expired, the number of new cases changed by a factor of 0.995 (95% CI, 0.994 to 0.995) in rural and 0.997 (95% CI, 0.995 to 0.999) in urban counties compared with prior to stay-at-home, while number of new deaths changed by a factor of 0.969 (95% CI, 0.968 to 0.970) in rural counties and 0.928 (95% CI, 0.926 to 0.929) in urban counties. Conclusion Stay-at-home orders decreased mobility, slowed the spread of COVID-19 and mitigated COVID-19 mortality, but did so less effectively in rural than in urban counties. This necessitates a critical re-evaluation of how stay-at-home orders are designed, communicated and implemented in rural areas.
Anesthesia Patient Safety: Next Steps to Improve Worldwide Perioperative Safety by 2030
Warner, Mark A., Arnal, Daniel, Cole, Daniel J., Hammoud, Rola, Haylock-Loor, Carolina, Ibarra, Pedro, Joshi, Muralidhar, Khan, Fauzia A., Lebedinskii, Konstantin M., Mellin-Olsen, Jannicke, Miyasaka, Katsuyuki, Morriss, Wayne W., Onajin-Obembe, Bisola, Toukoune, Robinson, Yazbeck, Patricia, Warner, Mark A., Arnal, Daniel, Cole, Daniel J., Hammoud, Rola, Haylock-Loor, Carolina, Ibarra, Pedro F. , Joshi, Muralidhar, Khan, Fauzia A., Лебединский, К. М. , Mellin-Olsen, Jannicke, Miyasaka, Katsuyuki, Morriss, Wayne W., Onajin-Obembe, Bisola, Toukoune, Robinson, Yazbeck, Patricia

Mayo Clinic

Anesthesia & Analgesia | April 7, 2022 | Volume: 135 | Issue: 1 | Pages: 6-19

10.1213/ane.0000000000006028 | PMID 35389378 Get It

Patient safety is a core principle of anesthesia care worldwide. The specialty of anesthesiology has been a leader in medicine for the past half century in pursuing patient safety research and implementing standards of care and systematic improvements in processes of care. Together, these efforts have dramatically reduced patient harm associated with anesthesia. However, improved anesthesia patient safety has not been uniformly obtained worldwide. There are unique differences in patient safety outcomes between countries and regions in the world. These differences are often related to factors such as availability, support, and use of health care resources, trained personnel, patient safety outcome data collection efforts, standards of care, and cultures of safety and teamwork in health care facilities. This article provides insights from national anesthesia society leaders from 13 countries around the world. The countries they represent are diverse geographically and in health care resources. The authors share their countries’ current and future initiatives in anesthesia patient safety. Ten major patient safety issues are common to these countries, with several of these focused on the importance of extending initiatives into the full perioperative as well as intraoperative environments. These issues may be used by anesthesia leaders around the globe to direct collaborative efforts to improve the safety of patients undergoing surgery and anesthesia in the coming decade.
Inequities in Therapy for Infantile Spasms: A Call to Action
Baumer, Fiona M. , Mytinger, John R. , Neville, Kerri, Abath, Christina Briscoe , Gutierrez, Camilo , Numis, Adam L. , Harini, Chellamani , He, Zihuai , Berg, Anne T. , Chu, Catherine J. , Gaillard, William D. , Pasupuleti, Archana, Samanta, Debopam , Singh, Rani K. , Singhal, Nilika S. , Wusthoff, Courtney J. , Yozawitz, Elissa , Shellhaas, Renée A. , Berg, Anne T , Chu, Catherine J , Baumer, Fiona M , Shellhaas, Renée A , Gaillard, William D , Yozawitz, Elissa G , Abath, Christina Briscoe , Wusthoff, Courtney J , Hussain, Shaun A. , Loddenkemper, Tobias , Wirrell, Elaine , Knupp, Kelly G. , Grinspan, Zachary M.

Mayo Clinic

Annals of Neurology | April 7, 2022 | Volume: 92 | Issue: 1 | Pages: 32-44

10.1002/ana.26363 | PMID 35388521 Get It

ObjectiveThe aim of this study was to determine whether selection of treatment for children with infantile spasms (IS) varies by race/ethnicity.MethodsThe prospective US National Infantile Spasms Consortium database includes children with IS treated from 2012 to 2018. We examined the relationship between race/ethnicity and receipt of standard IS therapy (prednisolone, adrenocorticotropic hormone, vigabatrin), adjusting for demographic and clinical variables using logistic regression. Our primary outcome was treatment course, which considered therapy prescribed for the first and, when needed, the second IS treatment together.ResultsOf 555 children, 324 (58%) were non‐Hispanic white, 55 (10%) non‐Hispanic Black, 24 (4%) non‐Hispanic Asian, 80 (14%) Hispanic, and 72 (13%) other/unknown. Most (398, 72%) received a standard treatment course. Insurance type, geographic location, history of prematurity, prior seizures, developmental delay or regression, abnormal head circumference, hypsarrhythmia, and IS etiologies were associated with standard therapy. In adjusted models, non‐Hispanic Black children had lower odds of receiving a standard treatment course compared with non‐Hispanic white children (odds ratio [OR], 0.42; 95% confidence interval [CI], 0.20–0.89; p = 0.02). Adjusted models also showed that children with public (vs. private) insurance had lower odds of receiving standard therapy for treatment 1 (OR, 0.42; CI, 0.21–0.84; p = 0.01).InterpretationNon‐Hispanic Black children were more often treated with non‐standard IS therapies than non‐Hispanic white children. Likewise, children with public (vs. private) insurance were less likely to receive standard therapies. Investigating drivers of inequities, and understanding the impact of racism on treatment decisions, are critical next steps to improve care for patients with IS. ANN NEUROL 2022;92:32–44
Ribociclib-Induced Pseudo-Acute Kidney Injury
Sy‐Go, Janina Paula T. , Yarandi, Niloufarsadat, Schwartz, Gary L. , Herrmann, Sandra M. , Herrmann, Sandra M

Mayo Clinic

Journal of Onco-Nephrology | April 7, 2022 | Volume: 6 | Issue: 1-2 | Pages: 64-69

10.1177/23993693221085285 Get It

The combination of endocrine therapy and cyclin-dependent kinase (CDK) 4/6 inhibitors is currently one of the preferred first-line regimens for patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer. CDK 4/6 inhibitors can cause serum creatinine (SCr) elevation and corresponding estimated glomerular filtration rate (eGFR) reduction without affecting kidney function by inhibiting tubular secretory transporters in the kidneys—a phenomenon called pseudo-acute kidney injury (pseudo-AKI). We report a case of a 69-year old woman found to have elevated SCr while on ribociclib for treatment of metastatic breast cancer. Further evaluation with cystatin C-based eGFR and measured GFR by urinary iothalamate clearance revealed values close to her baseline Cr-based eGFR prior to initiation of treatment with ribociclib. She was therefore diagnosed with ribociclib-induced pseudo-AKI. Treatment with ribociclib was continued with steady favorable response. This case highlights that, in addition to true AKI, ribociclib can cause pseudo-AKI. Alternative methods of kidney function assessment may be necessary in patients who develop elevated SCr while on this medication to help discriminate between artifactual and true kidney function impairment. Doing so can help avoid unnecessary work-up and/or premature discontinuation of the treatment.
Parotid sebaceous lymphadenoma associated with Sjogren’s syndrome: Review of pathologic and radiologic characteristics and clinical presentation
Janus, Jeffrey R. , Mzaik, Obaie, Bhatt, Alok A. , Bhatt, Alok A

Mayo Clinic

Journal of Clinical Imaging Science | April 7, 2022 | Volume: 12 | Issue: No issue available | Pages: 14

10.25259/jcis_14_2022 | PMID 35510245 Get It

Salivary lymphadenoma is an extremely rare neoplasm that is usually seen in the older patient population, arising sporadically on one side and almost exclusive to the parotid gland. Imaging and pathology findings can mimic both benign and malignant tumors, and therefore, this lesion may be misdiagnosed if not on the differential diagnosis. This article reviews the clinical presentation, as well as the pathology and imaging findings of salivary lymphadenoma in the setting of Sjogren’s syndrome.
Genome-wide expression reveals potential biomarkers in breast cancer bone metastasis
Singh, Yashbir , Subbarao, Naidu , Jaimini, Abhinav, Hathaway, Quincy A. , Kunovac, Amina , Swarup, Vishnu , Singh, Himanshu Narayan , Erickson, Bradley, Swarup, Vishnu , Singh, Himanshu Narayan , Singh, Yashbir , Hathaway, Quincy A , Erickson, Bradley J.

Mayo Clinic

Journal of Integrative Bioinformatics | April 7, 2022 | Volume: 19 | Issue: 3 | Pages: No page available

10.1515/jib-2021-0041 | PMID 35388653 Get It

Abstract Breast cancer metastases are most commonly found in bone, an indication of poor prognosis. Pathway-based biomarkers identification may help elucidate the cellular signature of breast cancer metastasis in bone, further characterizing the etiology and promoting new therapeutic approaches. We extracted gene expression profiles from mouse macrophages from the GEO dataset, GSE152795 using the GEO2R webtool. The differentially expressed genes (DEGs) were filtered by log2 fold-change with threshold 1.5 (FDR < 0.05). STRING database and Enrichr were used for GO-term analysis, miRNA and TF analysis associated with DEGs. Autodock Vienna was exploited to investigate interaction of anti-cancer drugs, Actinomycin-D and Adriamycin. Sensitivity and specificity of DEGs was assessed using receiver operating characteristic (ROC) analyses. A total of 61 DEGs, included 27 down-regulated and 34 up-regulated, were found to be significant in breast cancer bone metastasis. Major DEGs were associated with lipid metabolism and immunological response of tumor tissue. Crucial DEGs, Bcl3, ADGRG7, FABP4, VCAN, and IRF4 were regulated by miRNAs, miR-497, miR-574, miR-138 and TFs, CCDN1, STAT6, IRF8. Docking analysis showed that these genes possessed strong binding with the drugs. ROC analysis demonstrated Bcl3 is specific to metastasis. DEGs Bcl3, ADGRG7, FABP4, IRF4, their regulating miRNAs and TFs have strong impact on proliferation and metastasis of breast cancer in bone tissues. In conclusion, present study revealed that DEGs are directly involved in of breast tumor metastasis in bone tissues. Identified genes, miRNAs, and TFs can be possible drug targets that may be used for the therapeutics. However, further experimental validation is necessary.
Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbations
Patel, Tulsi , Carnwath, Troy , Wang, Xue , Allen, Mariet , Lincoln, Sarah, Lewis‐Tuffin, Laura J. , Quicksall, Zachary , Lin, Shu, Tutor‐New, Frederick Q, Ho, Charlotte C.G. , Min, Yuhao , Malphrus, Kimberly G., Nguyen, Thuy , Martin, Elizabeth, Al‐kharboosh, Rawan , Chaichana, Kaisorn L. , Wharen, Robert E. , Guerrero‐Cazares, Hugo , Quiñones‐Hinojosa, Alfredo , Ertekin‐Taner, Nilüfer , Carnwath, Troy P, Lincoln, Sarah J, Quicksall, Zachary S, Garcia, César A. , Alkharboosh, Rawan M, Chaichana, Kaisorn, Wharen, Robert, Ertekin-Taner, Nilüfer , Guerrero-Cazares, Hugo , Grewal, Sanjeet S.

Mayo Clinic

Aging Cell | April 7, 2022 | Volume: 21 | Issue: 5 | Pages: No page available

10.1111/acel.13606 | PMID 35388616 Get It

AbstractMicroglia have fundamental roles in health and disease; however, effects of age, sex, and genetic factors on human microglia have not been fully explored. We applied bulk and single‐cell approaches to comprehensively characterize human microglia transcriptomes and their associations with age, sex, and APOE. We identified a novel microglial signature, characterized its expression in bulk tissue and single‐cell microglia transcriptomes. We discovered microglial co‐expression network modules associated with age, sex, and APOE‐ε4 that are enriched for lipid and carbohydrate metabolism genes. Integrated analyses of modules with single‐cell transcriptomes revealed significant overlap between age‐associated module genes and both pro‐inflammatory and disease‐associated microglial clusters. These modules and clusters harbor known neurodegenerative disease genes including APOE, PLCG2, and BIN1. Meta‐analyses with published bulk and single‐cell microglial datasets further supported our findings. Thus, these data represent a well‐characterized human microglial transcriptome resource and highlight age, sex, and APOE‐related microglial immunometabolism perturbations with potential relevance in neurodegeneration.
Ventricular tachycardia targeted in the aortic sinuses of Valsalva in patients with prior myocardial infarction
Siontis, Konstantinos C. , Njeim, Mario, Dabbagh, Ghaith Sharaf , Yokokawa, Miki , Morady, Fred, Bogun, Frank

Mayo Clinic

Journal of Cardiovascular Electrophysiology | April 7, 2022 | Volume: 33 | Issue: 6 | Pages: 1199-1207

10.1111/jce.15486 | PMID 35388571 Get It

AbstractIntroductionVentricular tachycardia (VT) in structurally normal hearts or nonischemic cardiomyopathy can originate from the aortic sinuses of Valsalva (SoV). It is unknown whether VT can originate from the SoVs in patients with prior myocardial infarction (MI).ObjectiveTo evaluate the prevalence, arrhythmogenic substrate, and ablation outcomes of postinfarction VT originating from the SoVs.MethodsAmong 217 consecutive patients with postinfarction VT undergoing ablation, we identified 13 (6%) patients who had ≥1 VT mapped in a SoV. Control groups of 13 patients with idiopathic SoV VT and 13 postinfarction patients without SoV VT were included.ResultsIn the study group, 17 VTs were mapped in a SoV (right n = 5, left‐right commissure n = 6, left n = 6). SoV VT target sites had low bipolar voltage during sinus rhythm [median 0.42 (IQR: 0.16–0.53) mV] which was significantly lower than target sites in patients with idiopathic SoV VTs [median 1.02 (IQR: 0.89–1.52) mV; p < .001]. An area of endocardial low voltage was found below the aortic valve in all patients with postinfarction SoV VTs compared to 9 (69%) of the patients in the postinfarction control group without SoV VT (p = .02). Morphology characteristics of postinfarction SoV VTs differed from idiopathic SoV VTs. None of the postinfarction SoV VTs were inducible after ablation and none recurred after a median follow‐up of 14 months.ConclusionIn patients with prior MI, VT can be targeted in an aortic SoV. The SoVs should be routinely investigated in postinfarction patients with inferior axis VT and an area of low voltage below the aortic valve.
Latest updates in Mohs micrographic surgery for the management of penile squamous cell carcinoma
Assaf, Joy , Sarkis, Julien , Lilly, Eddy , Ghazi, Rabih , Sarkis, Pierre, Stéphan, Farid

Mayo Clinic

International Journal of Dermatology | April 7, 2022 | Volume: 61 | Issue: 9 | Pages: No page available

10.1111/ijd.16217 | PMID 35388468 Get It

What Cardiothoracic Radiologists Should Know About Imaging in Transgender Patients
Carroll, Evelyn F., Massoth, Lucas R., Stowell, Justin T., Carroll, Evelyn F., Massoth, Lucas R., Stowell, Justin T.

Mayo Clinic

Journal of Thoracic Imaging | April 6, 2022 | Volume: 37 | Issue: 5 | Pages: 269-278

10.1097/rti.0000000000000653 | PMID 35385859 Get It

Transgender and gender diverse (TGD) individuals may undergo a wide range of care during gender transition including mental health counseling, gender-affirming hormonal therapy, and various surgeries. Hormone therapy effectively converts the hormonal milieu into that of the affirmed gender and produces measurable alterations in serum markers for coronary artery disease and other hematologic conditions (eg, erythrocytosis, venous thrombosis). Although illegal in the United States, some transgender women may receive silicone injections for breast and soft tissue augmentation, which can lead to devastating local complications, as well as silicone migration, pulmonary embolism, systemic reactions, and death. Smoking rates are higher among transgender and sexual minority populations, placing them at elevated risk of smoking-related diseases, including lung cancer. Some opportunistic infections may be more common in the TGD populations, attributable to higher rates of coexisting infection with human immunodeficiency virus. Radiologists should be aware that these patients may develop cancer of their natal organs (eg, breast, prostate), especially as some of these tissues are not completely removed during gender-affirming surgery, which may manifest with thoracic involvement by secondary neoplasia. As more TGD patients seek medical care, thoracic radiologists can reasonably expect to interpret imaging performed in this population and should be aware of possible disease processes and potential complications of hormonal and surgical therapies.